Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A recent study, funded by Merck Research Laboratories, a division of Merck & Company, which manufactures and markets the Gardasil vaccine, is touting the drug for use not only as protection against cervical cancer, but also to prevent genital warts and other low-grade cervical growths. The study uses its findings to also promote expansion of the drug’s target market to include boys and young men. Previously, the drug has been targeted at girls beginning at age 9.

Read the rest of this entry »

Washington Examiner opinion editor Barbara Hollingsworth raises an interesting question about Merck’s cervical cancer vaccine Gardasil: If 52 deaths linked to sudden unintended acceleration in Toyota vehicles prompted massive, multi-billion-dollar recalls, then why is Gardasil still administered to thousands of school-age girls when it has been linked to 49 deaths in a briefer time span?

Read the rest of this entry »

Women considering receiving the Gardasil vaccine for themselves or their daughters  may encounter a lot of confusing, sometimes contradictory information and sweeping generalizations. Because January is Cervical Cancer Awareness month, more women and girls may be seeking information about human papillomavirus (HPV), Gardasil, and the more recently approved vaccine Cervarix, which makes it even more important that truth about the vaccine be known.

Read the rest of this entry »

When asked if she believed the Gardasil vaccine presented more risks to girls and women than the possibility of cervical cancer, Dr. Diane Harper, the lead researcher in human papilloma virus (HPV) vaccine development told journalist Marcia Yerman that Gardasil has little to no benefit for women who receive Pap screening.

Read the rest of this entry »

Merck and Co. announced yesterday that Dr. Julie Gerberding, the former director of the U.S. Centers for Disease Control and Prevention, will head the pharmaceutical giant’s vaccine division. Dr. Gerberding served as the CDC director from 2002 to 2009, stepping down when President Barack Obama took office.

Read the rest of this entry »

The Centers for Disease Control and Prevention recently rescinded its controversial and, some argued, discriminatory requirement that all girls and women ages 11 to 26 immigrating to the United States receive at least one injection of Gardasil, Merck’s human papillomavirus (HPV) vaccine.

Read the rest of this entry »

The Advisory Committee on Immunization Practices, which informs the U.S. Food and Drug Administration on vaccine use and policy, declined to advocate for Gardasil’s systematic and widespread use in boys and men. The human papilloma virus, or HPV, does not present the same risks of cancer in males as it does in females, but it can lead to the development genital warts.

Read the rest of this entry »

Dr. Diane Harper, the lead researcher in human papilloma virus (HPV) vaccine development, astonished her peers at the 4th International Public Conference on Vaccination last month when she spoke out against Merck’s Gardasil vaccination, rather than promote it as she was expected to do.

Read the rest of this entry »